Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.
Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans M, Clanet M, Radue EW, Kappos L; European IFN-1a in Relapsing MS Dose Comparison Trial Study Group.
Hardmeier M, et al. Among authors: radue ew.
Neurology. 2005 Jan 25;64(2):236-40. doi: 10.1212/01.WNL.0000149516.30155.B8.
Neurology. 2005.
PMID: 15668419
Clinical Trial.